OBJECTIVE: To examine the hypothesis that glial activation would regulate the expression of the N-methyl-D-aspartate receptor subunit 1 (NR1) in the trigeminal subnucleus caudalis (Sp5C) after temporomandibular joint (TMJ) inflammation. METHODS: Inflammation of TMJ was produced in rats by injecting 50 μL complete Freund's adjuvant (CFA) into unilateral TMJ space. Sham control rats received incomplete Freund's adjuvant injection. Mechanical nociception in the affected and non-affected TMJ site was tested by using a digital algometer. Fractalkine, fluorocitrate, and/or MK801 were intracisternally administrated to examine the relationship between astroglial activation and NR1 upregulation. RESULTS: CFA TMJ injection resulted in persistent ipsilateral mechanical hyperalgesia 1, 3, and 5 days after CFA injection. The inflammation also induced significant upregulation of CX3C chemokine receptor 1 and glial fibrillary acidic protein (GFAP) beginning on day 1 and of NR1 beginning on day 3 within the ipsilateral Sp5C. Intracisternal administration of fluorocitrate for 5 days blocked the development of mechanical hyperalgesia as well as the upregulation of GFAP and NR1 in the Sp5C. Conversely, intracisternal injection of fractalkine for 5 days exacerbated the expression of NR1 in Sp5C and mechanical hyperalgesia induced by TMJ inflammation. Moreover, once daily intracisternal fractalkine administration for 5 days in naïve rats induced the upregulation of NR1 and mechanical hyperalgesia. CONCLUSIONS: These results suggest that astroglial activation contributes to the mechanism of TMJ pain through the regulation of NR1 expression in Sp5C. Wiley Periodicals, Inc.
OBJECTIVE: To examine the hypothesis that glial activation would regulate the expression of the N-methyl-D-aspartate receptor subunit 1 (NR1) in the trigeminal subnucleus caudalis (Sp5C) after temporomandibular joint (TMJ) inflammation. METHODS:Inflammation of TMJ was produced in rats by injecting 50 μL complete Freund's adjuvant (CFA) into unilateral TMJ space. Sham control rats received incomplete Freund's adjuvant injection. Mechanical nociception in the affected and non-affected TMJ site was tested by using a digital algometer. Fractalkine, fluorocitrate, and/or MK801 were intracisternally administrated to examine the relationship between astroglial activation and NR1 upregulation. RESULTS:CFA TMJ injection resulted in persistent ipsilateral mechanical hyperalgesia 1, 3, and 5 days after CFA injection. The inflammation also induced significant upregulation of CX3C chemokine receptor 1 and glial fibrillary acidic protein (GFAP) beginning on day 1 and of NR1 beginning on day 3 within the ipsilateral Sp5C. Intracisternal administration of fluorocitrate for 5 days blocked the development of mechanical hyperalgesia as well as the upregulation of GFAP and NR1 in the Sp5C. Conversely, intracisternal injection of fractalkine for 5 days exacerbated the expression of NR1 in Sp5C and mechanical hyperalgesia induced by TMJ inflammation. Moreover, once daily intracisternal fractalkine administration for 5 days in naïve rats induced the upregulation of NR1 and mechanical hyperalgesia. CONCLUSIONS: These results suggest that astroglial activation contributes to the mechanism of TMJ pain through the regulation of NR1 expression in Sp5C. Wiley Periodicals, Inc.
Authors: C M Coughlan; C M McManus; M Sharron; Z Gao; D Murphy; S Jaffer; W Choe; W Chen; J Hesselgesser; H Gaylord; A Kalyuzhny; V M Lee; B Wolf; R W Doms; D L Kolson Journal: Neuroscience Date: 2000 Impact factor: 3.590
Authors: Maria D Rutkowski; Beth A Winkelstein; William F Hickey; Janice L Pahl; Joyce A DeLeo Journal: Spine (Phila Pa 1976) Date: 2002-08-01 Impact factor: 3.468
Authors: Catherine Abbadie; Jill A Lindia; Anne Marie Cumiskey; Larry B Peterson; John S Mudgett; Ellen K Bayne; Julie A DeMartino; D Euan MacIntyre; Michael J Forrest Journal: Proc Natl Acad Sci U S A Date: 2003-06-13 Impact factor: 11.205
Authors: P Bezzi; M Domercq; L Brambilla; R Galli; D Schols; E De Clercq; A Vescovi; G Bagetta; G Kollias; J Meldolesi; A Volterra Journal: Nat Neurosci Date: 2001-07 Impact factor: 24.884
Authors: P Lax; C Limatola; S Fucile; F Trettel; S Di Bartolomeo; M Renzi; D Ragozzino; F Eusebi Journal: J Neuroimmunol Date: 2002-08 Impact factor: 3.478
Authors: J Y Moon; D H Roh; S Y Yoon; S R Choi; S G Kwon; H S Choi; S Y Kang; H J Han; A J Beitz; S B Oh; J H Lee Journal: Br J Pharmacol Date: 2014-11-24 Impact factor: 8.739
Authors: Maria Lavinia Bartolucci; Ida Marini; Francesco Bortolotti; Daniela Impellizzeri; Rosanna Di Paola; Giuseppe Bruschetta; Rosalia Crupi; Marco Portelli; Angela Militi; Giacomo Oteri; Emanuela Esposito; Salvatore Cuzzocrea Journal: Inflamm Res Date: 2018-08-18 Impact factor: 4.575